Case Western Reserve University School of Medicine, Cleveland, OH, USA.
University Hospitals - Cleveland Medical Center, Cleveland, OH, USA.
Fam Cancer. 2022 Jan;21(1):115-120. doi: 10.1007/s10689-021-00239-z. Epub 2021 Mar 11.
The identification of hereditary cancer genes for esophageal adenocarcinoma (EAC) and its precursor, Barrett's esophagus (BE), may prove critical for the development of novel prevention and treatment strategies. Specifically, efforts for detecting BE and EAC susceptibility genes have focused on families with three or more affected members, since these individuals have an earlier age onset compared to non-familial individuals. Given that the use of BE may overestimate the likelihood of disease heritability, we evaluated the age of diagnosis in kindreds with a restricted definition including only confirmed high-grade dysplasia (HGD) or EAC. The Familial Barrett's Esophagus Consortium database was used to identify individuals with HGD and EAC. These individuals were subsequently split into three kindred groups: non-familial-a single affected family member, duplex-two affected family members, and multiplex-three or more affected family members. Age of cancer diagnosis and other risk factors were compared between individuals in these groups. The study included 441 non-familial, 46 duplex, and 13 multiplex individuals. There was a statistically significant difference for age of diagnosis for individuals in the multiplex families compared to the non-familial and duplex families (56.0 versus 64.3, 63.5; p = 0.049). There was no significant difference between demographic factors and other cancer risk factors between family types. The results of this study support a genetic basis for familial Barrett's associated neoplasia and evaluation of the genetic susceptibility to this disease should continue to focus on families with multiple (three or more) affected members.
遗传性食管癌 (EAC) 和其前体巴雷特食管 (BE) 癌基因的鉴定可能对新的预防和治疗策略的发展至关重要。具体来说,检测 BE 和 EAC 易感性基因的努力主要集中在有三个或更多受影响成员的家庭中,因为这些个体的发病年龄比非家族性个体更早。鉴于 BE 的使用可能高估疾病遗传性的可能性,我们评估了在仅限于确诊高级别异型增生 (HGD) 或 EAC 的家族中诊断的年龄。使用家族性 Barrett 食管协会数据库来识别患有 HGD 和 EAC 的个体。这些个体随后被分为三组家族:非家族性-一个受影响的家族成员,双发性-两个受影响的家族成员,多发性-三个或更多受影响的家族成员。在这些组中的个体之间比较了癌症诊断的年龄和其他风险因素。该研究包括 441 名非家族性、46 名双发性和 13 名多发性个体。多发性家族中个体的诊断年龄与非家族性和双发性家族相比具有统计学显著差异(56.0 与 64.3、63.5;p=0.049)。家族类型之间在人口统计学因素和其他癌症风险因素方面没有显著差异。这项研究的结果支持家族性 Barrett 相关肿瘤的遗传基础,并且对这种疾病的遗传易感性的评估应继续集中在有多个(三个或更多)受影响成员的家族上。